Answers are grounded in this paper and cite their sources.
Demonstrates antidiabetic potential of Grewia asiatica in animal models, suggesting a viable nutraceutical alternative.
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The increasing prevalence of diabetes worldwide has intensified the search for safer and more effective therapeutic alternatives. Medicinal plants have gained considerable attention due to their therapeutic potential, affordability, and relatively lower side effects. Grewia asiatica Linn., commonly known as Phalsa, is a medicinal plant widely distributed in South Asia and traditionally used for the treatment of various ailments. Recent pharmacological investigations have demonstrated significant antidiabetic activity of Grewia asiatica extracts in experimental animal models. The plant contains numerous bioactive compounds, including flavonoids, anthocyanins, phenolic acids, tannins, and alkaloids, which contribute to its antihyperglycemic, antioxidant, and anti-inflammatory activities. This article reviews the antidiabetic properties of Grewia asiatica based on animal studies, including its mechanisms of action and therapeutic potential for diabetes management.
No takes yet. Share an insight, caveat, or question.
and Dr. Amit Sharma (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: